Exome Sequencing Points to V600E BRAF Amplification in Some BRAF Inhibitor-Resistant Melanomas | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A University of California at Los Angeles-led team has identified a copy number change to the BRAF gene that coincides with drug resistance in a form of metastatic melanoma involving BRAF mutation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.